676127-84-7

Basic information

• Product Name: 2-Azetidinone, 3-butyl-1-(phenylmethoxy)-, (3R)-
• CAS NO: 676127-84-7
• Molecular Formula: C14H19NO2
• Molecular Weight: 233.31
• Mol File: 676127-84-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-Azetidinone, 3-butyl-1-(phenylmethoxy)-, (3R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Azetidinone, 3-butyl-1-(phenylmethoxy)-, (3R)-(676127-84-7)
• EPA Substance Registry System: 2-Azetidinone, 3-butyl-1-(phenylmethoxy)-, (3R)-(676127-84-7)

Safety Data

• Hazardous Substances Data: 676127-84-7(Hazardous Substances Data)

Usage

Type

Local anesthetic medication

Drug Class

Amide-type local anesthetics

Mechanism of Action

Blocks transmission of nerve signals in the body

Common Uses

Epidural, spinal, and nerve block anesthesia during surgeries, childbirth, and other medical procedures

Administration

Given by healthcare professionals

Side Effects

Dizziness, drowsiness, allergic reactions

Upstream product

• 143965-32-6 (4S)-3-hexanoyl-4-(phenylmethyl)-1,3-oxazolidin-2-one 
• 29601-98-7 N-benzylhydroxylamine hydrochloride 
• 668485-39-0 (4S)-3-[(2R)-2-(hydroxymethyl)hexanoyl]-4-(phenylmethyl)-1,3-oxazolidin-2-one 
• 142-61-0 Hexanoyl chloride 
• 676127-81-4 (2R)-2-(hydroxymethyl)-N-[(phenylmethyl)oxy]hexanamide 
• 2985-32-2 butylmalonic acid monoethyl ester 
• 58243-89-3 (±)-2-butyl-3-hydroxypropionic acid 
• 2612-26-2 2-butylpropane-1,3-diol 
• 2687-43-6 O-benzylhydoxylamine hydrochloride 

Downstream Products

• 676127-79-0 C₂₄H₃₁FN₄O₃ 
• 478913-91-6 (S)-1-{(R)-2-[(Formyl-hydroxy-amino)-methyl]-hexanoyl}-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide 
• 478913-92-7 (2S)-N-(5-fluoro-2-pyridinyl)-1-[(2R)-2-[formyl(phenylmethoxy)amino]methyl]-1-oxohexyl-2-pyrrolidinecarboxamide 
• 478913-93-8 (2S)-N-(5-fluoro-1-oxido-2-pyridinyl)-1-[(2R)-2-[[formyl(phenylmethoxy)amino]methyl]-1-oxohexyl]-2-pyrrolidinecarboxamide 
• 301685-23-4 (2R)-2-({formyl[(phenylmethyl)oxy]amino}methyl)hexanoic acid 
• 234768-83-3 (2R)-2-({[(phenylmethyl)oxy]amino}methyl)hexanoic acid 
• 1281973-29-2 C₂₅H₃₁FN₄O₆ 
• 1101196-96-6 C₂₄H₂₉FN₄O₆ 
• 1101196-50-2 C₂₂H₃₂N₄O₆ 
• 1101196-49-9 C₂₂H₃₁ClN₄O₆ 
• 1101196-48-8 C₂₂H₃₁FN₄O₆ 
• 1101196-47-7 C₁₉H₂₇N₃O₆ 
• 1281973-30-5 C₁₈H₂₃F₂N₃O₅ 
• 1101196-45-5 C₁₈H₂₄FN₃O₅ 

Relevant articles and documents

Peptide deformylase inhibitors

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhibition of bacterial peptide deformylase (PDF) activity.

Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors

The drug resistant bacteria pose a severe threat to human health. The increasing resistance of those pathogens to traditional antibacterial therapy renders the identification of new antibacterial agents with novel antibacterial mechanisms an urgent need.

β-amino amides from β-lactams: Application to the formal synthesis of a peptide-deformylase inhibitor

A facile and a practical synthesis of peptide-deformylase inhibitor 1 is described using an acid-catalyzed aminolysis of β-lactam 12 with pyrrolidine 6 as the key transformation. In addition, simplified conditions for the conversion of a β-hydroxy acid to